Search Results – Inserm Transfert

Our Technology Offers

Welcome to our Technology Offers website

You want access to an innovative offer which is based on the excellence of Inserm, the leading academic research and clinical institute dedicated to human health in Europe? Find out our technologies offers of patents and research tools: here is a sample of our patents.

BIO19135-T1

Drug Field of development:

Allergies Therapy Area:

Product Type of patent:

Targeting the secreted ige poly-a signal allows specific inhibition of

Immunoglobulins (Ig) are expressed either on the surface of B cells or as secreted antibodies by plasma cells that represents the final stage of B […]

BIO21052-T1

Drug Field of development:

Left ventricular dysfunction Therapy Area:

Product Type of patent:

Methods for improving relaxation of striated myocytes

The Inventors developed conditions allowing to efficiently detect differences in cardiomyocytes relaxation phases associated with increased […]

BIO16235-T1

Drug Field of development:

Type 2 Diabetes Therapy Area:

Product Type of patent:

Methods of enhancing the potency of incretin-based drugs in subjects

The present invention relates to methods of enhancing the potency of incretin-based drugs in subjects in need thereof. Through different animal […]

BIO13310-T1

Drug Field of development:

Chronic Heart Failure Therapy Area:

Product Type of patent:

Apelin analogs for the treatment of heart failure

The invention related to metabolically stable Apelin analogs and their use for the prevention or the treatment of diseases mediated by the apelin […]

BIO20498-D1

Biomarker Field of development:

Liver Disease Therapy Area:

Method Type of patent:

Bile salts bactosensor and use thereof for diagnostic and therapeutic

Bile salts are steroid acids derived from cholesterol in the liver, are released into the gastrointestinal tract to aid in digestion and are […]

BIO18215-T1

Drug Field of development:

Thalassemia Therapy Area:

Product Type of patent:

Methods for increasing fetal hemoglobin content in eukaryotic cells

The clinical severity of β-hemoglobinopathies is alleviated by the co-inheritance of genetic mutations causing a sustained fetal γ-globin chain […]

BIO17685-T1

Drug Field of development:

Type 1 Diabetes (Juvenile Diabetes) Therapy Area:

Product Type of patent:

Antigenic peptides deriving from urocortin 3 and uses thereof for the

Despite the notion that human CD8+ T cells are the final mediators of autoimmune β- cell destruction in type 1 diabetes (T1D), none of their target […]

BIO17684-T1

Drug Field of development:

Type 1 Diabetes (Juvenile Diabetes) Therapy Area:

Product Type of patent:

Antigenic peptides deriving from pcsk2 and uses thereof for the

Despite the notion that human CD8+ T cells are the final mediators of autoimmune β-cell destruction in type 1 diabetes (T1D), none of their target […]

BIO17382-T1

Drug Field of development:

Type 1 Diabetes (Juvenile Diabetes) Therapy Area:

Product Type of patent:

Antigenic peptides deriving from secretogranin v and uses thereof for

Despite the notion that human CD8+ T cells are the final mediators of autoimmune β- cell destruction in type 1 diabetes (T1D), none of their target […]

BIO19217-T1

Drug Field of development:

Hemophilia Therapy Area:

Product Type of patent:

Anti- protease nexin-1 conformational single domain antibodies and

The present invention relates to anti-protease nexin-1 (PN-1) conformational single domain antibodies and uses thereof in particular in the […]

147

56

310

46

Our Technology Offers

Targeting the secreted ige poly-a signal allows specific inhibition of

Methods for improving relaxation of striated myocytes

Methods of enhancing the potency of incretin-based drugs in subjects

Apelin analogs for the treatment of heart failure

Bile salts bactosensor and use thereof for diagnostic and therapeutic

Methods for increasing fetal hemoglobin content in eukaryotic cells

Antigenic peptides deriving from urocortin 3 and uses thereof for the

Antigenic peptides deriving from pcsk2 and uses thereof for the

Antigenic peptides deriving from secretogranin v and uses thereof for

Anti- protease nexin-1 conformational single domain antibodies and

You might also be interested in

Cd38 as a biomarker and biotarget in

Methods and compositions for treating triple

Method for diagnosing colorectal cancer

Methods for improving the efficacy of hdac

Early and non-invasive method for assessing a

New biomarkers of alcohol use disorders

New method to diagnose inflammatory diseases

Methods and kits for identifying and quantifying

Ivig composition and method of treatment of

Nanobody against ela2a to treat inflammatory bowel

Targeting the secreted ige poly-a signal allows

Methods and compositions for treating cell

Contact

Inserm Transfert